Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| oligodendrocyte | 11 studies | 37% ± 14% | |
| adipocyte | 8 studies | 39% ± 12% | |
| GABAergic neuron | 6 studies | 43% ± 19% | |
| glutamatergic neuron | 5 studies | 43% ± 15% | |
| astrocyte | 5 studies | 47% ± 20% | |
| interneuron | 5 studies | 50% ± 20% | |
| cardiac muscle cell | 5 studies | 47% ± 12% | |
| GABAergic amacrine cell | 3 studies | 40% ± 6% | |
| glycinergic amacrine cell | 3 studies | 24% ± 6% | |
| hepatocyte | 3 studies | 36% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| thymus | 100% | 1719.31 | 652 / 653 | 80% | 3.41 | 487 / 605 |
| breast | 97% | 1375.36 | 443 / 459 | 78% | 6.99 | 872 / 1118 |
| liver | 86% | 283.03 | 194 / 226 | 75% | 2.22 | 306 / 406 |
| prostate | 87% | 694.66 | 212 / 245 | 53% | 1.03 | 268 / 502 |
| brain | 57% | 219.96 | 1500 / 2642 | 61% | 2.22 | 433 / 705 |
| ovary | 100% | 1446.29 | 180 / 180 | 11% | 0.24 | 47 / 430 |
| ureter | 0% | 0 | 0 / 0 | 100% | 1.07 | 1 / 1 |
| muscle | 100% | 1083.65 | 800 / 803 | 0% | 0 | 0 / 0 |
| adrenal gland | 23% | 74.00 | 60 / 258 | 74% | 4.13 | 171 / 230 |
| blood vessel | 94% | 849.72 | 1257 / 1335 | 0% | 0 | 0 / 0 |
| uterus | 78% | 731.09 | 133 / 170 | 14% | 0.40 | 65 / 459 |
| skin | 80% | 558.01 | 1456 / 1809 | 10% | 0.38 | 48 / 472 |
| heart | 88% | 834.52 | 756 / 861 | 0% | 0 | 0 / 0 |
| adipose | 84% | 746.15 | 1014 / 1204 | 0% | 0 | 0 / 0 |
| esophagus | 53% | 540.22 | 768 / 1445 | 25% | 1.23 | 45 / 183 |
| intestine | 37% | 136.89 | 354 / 966 | 17% | 0.47 | 90 / 527 |
| lung | 18% | 41.67 | 103 / 578 | 32% | 1.09 | 367 / 1155 |
| stomach | 25% | 95.12 | 89 / 359 | 22% | 0.67 | 62 / 286 |
| pancreas | 1% | 1.14 | 2 / 328 | 45% | 1.17 | 80 / 178 |
| kidney | 9% | 30.21 | 8 / 89 | 29% | 0.72 | 264 / 901 |
| bladder | 0% | 0 | 0 / 21 | 21% | 0.68 | 105 / 504 |
| tonsil | 0% | 0 | 0 / 0 | 4% | 0.06 | 2 / 45 |
| eye | 0% | 0 | 0 / 0 | 3% | 0.03 | 2 / 80 |
| spleen | 1% | 2.02 | 3 / 241 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0001656 | Biological process | metanephros development |
| GO_0003231 | Biological process | cardiac ventricle development |
| GO_0007275 | Biological process | multicellular organism development |
| GO_0001658 | Biological process | branching involved in ureteric bud morphogenesis |
| GO_0061205 | Biological process | paramesonephric duct development |
| GO_0001822 | Biological process | kidney development |
| GO_0030539 | Biological process | male genitalia development |
| GO_0072177 | Biological process | mesonephric duct development |
| GO_0060065 | Biological process | uterus development |
| GO_0016020 | Cellular component | membrane |
| Gene name | GREB1L |
| Protein name | GREB1-like protein (Growth regulation by estrogen in breast cancer 1-like protein) GREB1 like retinoic acid receptor coactivator |
| Synonyms | C18orf6 KIAA1772 |
| Description | FUNCTION: Plays a major role in early metanephros and genital development. . |
| Accessions | ENST00000424526.7 [Q9C091-1] ENST00000580384.1 J3QR03 ENST00000580732.6 [Q9C091-1] ENST00000581327.1 J3QQW0 ENST00000579454.2 ENST00000269218.10 [Q9C091-3] Q9C091 J3KRT4 |